Endocrine treatment may be beneficial for patients with<unk> s. There are two ways for treating these kind of<unk> s: * Lowering systemic levels of estrogen, achieved by the use of drugs from the aromatase inhibitor category. These drugs target one of the enzymes that takes part in the biosynthesis of estrogen. * Blockage of the estrogen<unk> s on the cancerous cells, thus preventing estrogen binding, leading to decreased proliferation. Drugs in this category are also referred to as SERMs (Selective estrogen<unk>  modulator) since they are able to block estrogen<unk> s in a selective manner.
Hormone receptor positive breast tumor
Hormone-sensitive cancer
Hereditary lobular breast cancer
Endocrine therapy resistance in breast cancer
Triple-negative breast cancer
Benign proliferative breast disease
Pre-cancer of the breast
Metastatic breast cancer